Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes
暂无分享，去创建一个
A. Brunner | U. Germing | I. Avivi | U. Platzbecker | D. Lavie | P. Mistry | J. Lauring | A. Alfonso | A. Kalota | D. Morillo | Tamanna Haque | M. Preis | B. Xicoy | D. Valcárcel | H. Leitch | L. Lenox | J. Falantes | F. Pastore | J. Chromik | M. Patel | Jaydeep Mehta | F. L. Cadenas | Regina J Brown